Origen de la red de primer grado Mark Lewis.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.
11
| Holding Company | Packaged Software | 11 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mark Lewis a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
GT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity | |
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
Vascular Pathways, Inc.
Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Director/Board Member | |
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA. | Biotechnology | Director/Board Member | |
EVOLUS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Chief Investment Officer Private Equity Investor | |
University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Graduate Degree | |
Lock Haven University of Pennsylvania | College/University | Undergraduate Degree | |
University of Arizona | College/University | Undergraduate Degree | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree | |
Intermediate Capital Group Plc (Private Equity)
Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Sailing Capital Management Co. Ltd.
Sailing Capital Management Co. Ltd. Investment ManagersFinance Shanghai Sailing Capital Management Co. Ltd. (Sailing Capital) is a private equity firm founded in 2011. The firm is headquartered in Shanghai. | Investment Managers | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
MVM (U.S.), Inc.
MVM (U.S.), Inc. Investment ManagersFinance Part of MVM Partners LLP, MVM (U.S.), Inc. provides investment advice. The company is based in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Other | Director/Board Member | |
EXICURE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Sailing Capital Advisors Hong Kong Ltd
Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Investment Managers | Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Adaptate Biotherapeutics Ltd.
Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Launch Therapeutics, Inc.
Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member | |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 30 |
Reino Unido | 12 |
Hong-Kong | 3 |
Francia | 2 |
Países Bajos | 2 |
Sectorial
Health Technology | 25 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 4 |
Health Services | 2 |
Operativa
Director/Board Member | 76 |
Corporate Officer/Principal | 19 |
Independent Dir/Board Member | 18 |
Chairman | 11 |
Private Equity Investor | 9 |
Las relaciones más conectadas
Insiders | |
---|---|
John McKearn | 25 |
Peter Kiener | 25 |
Bosun Hau | 23 |
Mark Alles | 20 |
Bali Muralidhar | 20 |
Natalie Mount | 10 |
Kumar Srinivasan | 7 |
Kevin Kaijun Li | 5 |
Matthew Cooper | 1 |
Ayman Kabakibi | 1 |
Drew Dennison | 1 |
- Bolsa de valores
- Insiders
- Mark Lewis
- Conexiones Empresas